Exquintia
Sectoren

Sector | Pharma and fine chemicals

Why Exquintia for pharma and fine chemicals?

In pharma and fine chemicals, explosion safety intersects with product quality, containment, cleaning, validation, maintenance and process safety.

Exquintia supports companies with ATEX assessment of production, laboratories, pilot plants, utilities, maintenance and engineering.

01

Regulated process environments

ATEX measures must be technically correct and fit within GMP workflows, containment, cleaning, maintenance and documentation.

Exquintia assesses explosion safety as part of the real process and lifecycle of the installation.

02

Typical support

Exquintia supports pharma and fine-chemical companies with:

  • explosion protection documentation
  • ATEX zoning for solvents, vapours and powders
  • inspection of Ex installations and documentation
  • ignition source and process risk analysis
  • assessment of change control and MOC
  • audit preparation and independent dossier review
03

Result

You gain a clear view of explosion risks in production, laboratories, pilot plants or utilities, including critical installations, ignition sources, missing documentation and priority improvements.

Concrete entry point

Choose directly why you involve Exquintia.

Not a generic contact step, but a clear route for EPD, zoning, inspection regime and explosion safety risks.

Request an ATEX intake

For companies that want to know whether their EPD, zoning or inspection regime is still up to date.

Request intake

Have your EPD reviewed for auditability

For companies that already have a document, but doubt whether it holds up technically and legally.

Review EPD

Request an explosion safety quickscan

For battery charging areas, dust installations, food/feed, utilities, water treatment and maintenance situations.

Request quickscan

Do you work with solvents, APIs, powders or batch processes?

Have your pharma or fine-chemical process independently reviewed for ATEX risk, documentation, cleanroom practice and auditability.

Review your pharma ATEX dossier